| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Problem-Solving Success Tip: Plan for Things to Go Wrong |
|
Advice You - Problem-Solving Success Tip: Plan for Things to Go Wrong
Plan for things to go wrong. We’ve heard it before, and it’s still true: if something c According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product an go wrong, it will. Figure out ahead of time where your problem solving effort is vulnerable ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in nd develop appropriate contingency plans. Start on this as soon as you begin the problem-solvin lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. effort, making it a normal part of defining a problem. Vulnerabilities are all the thi here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe gs that could prevent your problem-solving project from succeeding. Typical vulnerabilities inc d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ude changing priorities, inadequate resources (people, money, time), staff turnover, key player ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc unable or unwilling to participate, other projects not getting completed on time, etc. Of cour easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e, the list will be different for each problem, and the probability that any particular vulnera nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ility will occur varies as well. The key is to identify them, and assess each one for probabili and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ y of occurrence and impact on the project if it should occur. Develop contingency plans immedi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi tely for any that have both a high probability of occurring and a high impact. You may also wan ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a to develop contingency plans for low probability/high impact issues. Low impact issues, especi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod lly if the probability is low, are probably not worth significant contingency planning. You wi cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin l need to monitor your environment throughout the problem-solving project so that you’ll know < tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen >early if any of the vulnerabilities show signs of occurring. Your monitoring program shoul t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel always include regular communication with all participants in your problem-solving project as ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ell as with the leaders of any projects you are depending on. You’ll want to let these people k y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ow either that everything is on track or, if a vulnerability is materializing, that you know ab . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ut it, are executing an appropriate contingency plan, and understand what implications there ar elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip for the problem-solving effort as a whole. Copyright 2006. Jeanne Sawyer. All Rights Reserved tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Hot Air Balloons and Your Business Case Study: High Aspirations Key to High Performance Technologies' Success Sources Of Knowledge - How To Gain Knowledge In Any Field
|